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Abstract
Background: With microarray technology, variability in experimental environments such as RNA
sources, microarray production, or the use of different platforms, can cause bias. Such systematic
differences present a substantial obstacle to the analysis of microarray data, resulting in inconsistent
and unreliable information. Therefore, one of the most pressing challenges in the field of
microarray technology is how to integrate results from different microarray experiments or
combine data sets prior to the specific analysis.
Results: Two microarray data sets based on a 17k cDNA microarray system were used, consisting
of 82 normal colon mucosa and 72 colorectal cancer tissues. Each data set was prepared from
either total RNA or amplified mRNA, and the difference of RNA source between these two data
sets was detected by ANOVA (Analysis of variance) model. A simple integration method was
introduced which was based on the distributions of gene expression ratios among different
microarray data sets. The method transformed gene expression ratios into the form of a reference
data set on a gene by gene basis. Hierarchical clustering analysis, density and box plots, and mixture
scores with correlation coefficients revealed that the two data sets were well intermingled,
indicating that the proposed method minimized the experimental bias. In addition, any RNA source
effect was not detected by the proposed transformation method. In the mixed data set, two
previously identified subgroups of normal and tumor were well separated, and the efficiency of
integration was more prominent in tumor groups than normal groups. The transformation method
was slightly more effective when a data set with strong homogeneity in the same experimental
group was used as a reference data set.
Conclusion: Proposed method is simple but useful to combine several data sets from different
experimental conditions. With this method, biologically useful information can be detectable by
applying various analytic methods to the combined data set with increased sample size.
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Background
DNA microarrays are a useful tool for the study of com-
plex systems and have applications in a wide variety of
biological sciences. Despite their usefulness, however, sys-
tematic biases caused by different handling procedures
present a challenge. Microarray experiments are often per-
formed over many months, and samples are often col-
lected and processed at different institutions. Further, the
samples may be assayed using different microarray print
batches or platforms, or using different array hybridiza-
tion protocols. When two microarray data sets are directly
compared, systematic biases arising from variability in
experimental conditions can be erroneously detected as
differences in gene expression patterns. Such systemic
biases present a substantial obstacle in the analysis of
microarray data. However, due to the limited numbers of
available microarray experiments, the motivation to use
an entire data set regardless of platforms or experimental
procedure is increasing. Therefore, it is necessary to inves-
tigate new methods that can effectively combine microar-
ray data sets which were derived from different
experimental environments, while simultaneously mini-
mizing systematic bias.
A commonly utilized method to integrate microarray data
sets is to focus on the differential expression, i.e. compar-
ing significantly expressed genes selected separately from
each data set [1-7]. Another type of comparison examines
the variability in gene expressions between human and
mouse data sets combining the different microarray plat-
forms [4]. These studies exploit multiple data sets, rather
than a single data set, in order to obtain more robust
result. Some studies overcome the limitations of a single
microarray data set using integration technique, since
integration of separate data sets has the similar effect as
increasing sample size [8]. However, a suitable integration
method has not yet been established. Indeed, some stud-
ies suggest that microarray data sets derived from different
experimental processes cannot be combined directly, as
they are poorly correlated with each other [9].
Recently, the practice of integrating data sets prior to
selecting significant genes was introduced and standardi-
zation has been used for this as the simplest method [10].
Singular Value Decomposition (SVD) corrects systematic
bias of data sets and has been used in yeast cell cycle
experiments [11] and in data sets containing samples
from many soft tissue tumors [12]. Although SVD is a use-
ful method for determining the direction of large varia-
tions so that systematic effects can be removed, it has been
suggested that SVD is inappropriate for cases where the
magnitude of the systematic variation is similar to the
components of other variations [13]. Alternatively, Dis-
tance Weighted Discrimination (DWD), which is a modi-
fied form of SVM that adjusts for systematic effects,
performed well and could eliminate source effects [13].
However, DWD could not regulate the dispersion of dif-
ferent data sets.
A method that transforms the distributions of gene
expressions of two data sets similarly was proposed [14].
However, this method did not consider biological differ-
ences between the two different experimental groups,
such as normal and tumor, because they used the average
expression value of these two groups to define a reference
sample. A recent study introduced an ANOVA, Analysis of
Variance, model to select discriminative genes from sev-
eral datasets derived from different experimental environ-
ments [15]. This method can be flexible to consider any
clinical variables as well as genetic information including
several effect factors, which represent experimental condi-
tions. But, with this method, we can not evaluate how
well datasets are intermixed, and explore expression pat-
terns of any interesting genes in combined data set. There-
fore, we suggested a method to effectively integrate
different experimental environments and evaluated its
efficiency using mixture score.
Results
Seventy-eight experiments (43 tumor and 35 normal)
from data set A and 76 experiments (39 tumor and 37
normal) from data set B were used in this study. The
whole data set included missing entries in the range of
448 to 1298 genes for each experiment. A total of 12293
genes without missing entries were used for further analy-
sis.
Exploration of expression patterns of two data sets before 
transformation
We confirmed RNA source effect in more than 5000 genes
by ANOVA using adjusted p-value of 0.05 by Bonferroni
correction (data not shown). The numbers of genes which
were significantly differentially expressed between two
experimental groups were 2325 and 1654 in data set A
and data set B, respectively. This showed that there was
some difference in sensitivity between two data sets. Even
in same experimental group, there were many genes that
expressed differently between two data sets, 4668 genes in
normal group and 3364 in tumor group. The significant
difference between different experimental groups, normal
and tumor groups, was not detected by RNA source effect
in these genes. Figure 1 shows the distribution of p-values
for differently expressed genes based on two data sets.
As shown in Figure 2, there were considerable differences
in the scales and locations of expression ratios of five ran-
domly selected genes from two data sets, even in the same
group, prior to transformation of gene expression. Data
set B seemed to have larger variation than data set A inBMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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expression ratios in both tumor and normal groups, and
tumor groups had large dispersions in two data sets.
In analyzing the five randomly selected genes with density
plots, we found significant differences in locations of the
first four genes, and in dispersions of gene203 and
gene5112 between the two data sets (Figure 3). If the data
sets are analyzed without transformation, gene203 and
gene5112 in data set B, whose variations of expression
ratios were larger in data set B compared with data set A,
is relatively more influential than the same genes of data
set A in further analysis. Likewise, because of the large dif-
ferences in locations of gene160 and gene1793 between
the two data sets, these genes might not be selected as dis-
criminative genes classifying the two different experimen-
tal groups.
Figure 4 shows that data set A had a stronger relationship
within experimental groups compared to data set B, indi-
cating that data set A is more homogeneous than data set
B. However, the within-group correlations in tumor
groups were lower than those within the normal groups in
both data sets. Actually, average correlation coefficients
within normal groups were 0.85 and 0.81, and 0.72 and
0.68 within tumor groups in data set A and data set B,
respectively. This can be explained by the fact that the
tumor groups showed larger variations than the normal
groups, due to variability in biological conditions includ-
ing different disease stages.
As the normality assumption is necessary for applying t-
test, Q-Q plot was evaluated. The two separate data sets
did not satisfy the normality assumption in normal and
tumor groups before combining two data sets as shown in
Figure 5. This figure also indicates that data set B had
larger variation than data set A for both tumor and normal
groups. However, the normality in the combined data set
was improved even though no transformation was
applied to two data sets. It can be interpreted that the
combined data set slightly follows a normal distribution
due to the increased sample size resulting from the com-
bining of the two data sets. It indicates that the integration
of two data sets is essential for reliable result.
Exploration of expression patterns of combined data sets 
after transformation
As explained in the "Methods", A'B transforms data set A
referring to data set B and AB' transforms data set B refer-
ring to data set A. A'B' transforms data set A and data set B
using pooled standard deviation and combines them. The
variations observed in data sets transformed by the A'B
and AB' methods changed depending on the variations of
the reference data set (Figure 6). The A'B' method trans-
formed expression patterns of the two data sets using a
pooled standard deviation and corrected the difference in
variations of them. We observed that the differences in
location and variation between the two data sets were
adjusted by the proposed methods preserving the respec-
tive expression patterns.
Data set A had higher within-group correlation than data
set B prior to integration, indicating that experiments in
data set A had more homogeneous expression pattern
than data set B (Figure 4). The tumor groups had lower
correlations than the normal groups in both data sets,
indicating that there were larger variations within the
tumor groups than the normal groups. Within-group cor-
relations of the combined data sets after transformation
were increased comparing to the result shown in Figure 4
Comparison of the distributions of p-values for differently  expressed genes based on two data sets Figure 1
Comparison of the distributions of p-values for differently 
expressed genes based on two data sets. Two sample t-test 
was executed for selection of significantly differently 
expressed genes between two data sets. (AN-BN: normal 
groups of data set A and data set B, AT-BT: tumor groups of 
data set A and data set B, ABN-ABT: normal group and 
tumor group of combined data set without transformation)BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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(Figure 7). The homogeneity of the combined data set A'B
was similar to that of data set B, because data set A'B was
resulted from the transformation of data set A into the
expression pattern of data set B with low homogeneity
within group. Similarly, data set AB' preserved relatively
strong homogeneity, by transforming into expression pat-
terns of data set A with higher correlation than data set B.
Data set A'B', which was transformed by the weighted
average of the dispersions of the two data sets, had an
average degree of homogeneity of A'B and AB', but still
had a low correlation in the tumor group. The data sets
integrated by the proposed transformation methods had
higher correlations within groups than the integrated data
set without transformation, indicating that the proposed
transformation methods effectively preserved homogene-
ity within groups of separate data sets.
Hierarchical cluster analysis (HCA) clustered the samples
into two distinct groups according to the data sources
rather than different experimental groups (Figure 8AB).
However, Figure 8A'B, AB' and 8A'B' showed that the
experimental groups (tumor or normal) of the two data
sets were more distinctly separated regardless of the trans-
formation methods. HCA also showed that the two data
sets were in fact well intermingled, indicating that the
experimental bias had been minimized. Intermingling of
different data sets indicates that data sets derived from dif-
ferent experimental conditions are combined well for fur-
ther analysis.
Boxplots for expression ratios of five randomly selected genes in normal and tumor groups Figure 2
Boxplots for expression ratios of five randomly selected genes in normal and tumor groups. AN, AT, BN and BT are normal 
and tumor groups in data set A and data set B, respectively.
Density plots of five randomly selected genes from the data sets of (N) normal and (T) tumor groups (red: data set A, blue:  data set B) Figure 3
Density plots of five randomly selected genes from the data sets of (N) normal and (T) tumor groups (red: data set A, blue: 
data set B). Horizontal and vertical axes represent gene expression and relative frequency, respectively.BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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The degree of mixture was measured by the mixture score.
Euclidean distance and Pearson correlation coefficient
were used as similarity measures to calculate the mixture
score, and k was considered from 5 to 35 as a number of
nearest neighbors (NNs). From the mixture scores before
transformation, we found that the normal groups of data
sets A and data set B were hardly intermixed (Figure 9).
On the other hand, the tumor groups from the two data
sets tended to be slightly intermixed, as the number of
NNs increased before transformation. After transforma-
tion, the mixture scores were increased up to 42.9% in the
tumor group as the number of NNs increased, suggesting
that two data sets were well intermixed. In addition, these
values were similar in Euclidean distance (data not
shown) and Pearson correlation coefficient. Dataset AB'
had the highest within-group correlation indicating that
strong homogeneity exists in combined data set as shown
in Figure 7, and its mixture score also was the largest as
shown in Figure 9. Dataset A'B and A'B' were well inter-
mixed although AB' had the highest mixture score and
there were not considerable differences among them.
Also, all of the proposed transformation methods were
more effective in the tumor group than in the normal
group, showing tumor groups were intermixed better than
normal groups even before transformation. This can be
interpreted that the characteristics of the original data set
were preserved in the integrated data set after transforma-
tion.
Comparison of significant gene sets selected by 
transformation methods
Table 1 shows the number of differently expressed genes
using t-test for each transformation method. Adjusted p-
values of 0.05 and 0.01 by Bonferroni correction were
used as the significant levels.
As shown in Table 1, a larger number of significant genes
were identified in data set AB' compared to other data sets.
With the adjusted p-value of 0.01, 3868 and 2488 genes
were identified by the AB' and AB method, respectively.
This can be interpreted that data set AB' had large t-statis-
tics due to the large mean differences and small variations
in expression levels between two experimental groups
with strong homogeneity. In ANOVA model excluding
interaction term, 3004 significant genes were detected and
it showed that the performance of ANOVA model is better
than the use of combined data set prior to transformation,
AB. However, its performance was lower than data sets
transformed by our method, A'B, AB' and A'B', in compar-
ison of the number of significant genes.
We compared the degree of concurrency in top 500 signif-
icant genes which are selected from combined data sets.
Two hundred fifty genes out of top 500 genes selected
from data set A were consistent with gene set selected from
data set B. Among 750 genes, which is union gene set of
top 500 genes of data set A and data set B, 496, 492, and
488 genes were consistent with top 500 genes of A'B, AB'
and A'B', respectively. And 457 genes were consistent with
Q-Q plots of a randomly selected genes in (N) normal and  (T) tumor groups Figure 5
Q-Q plots of a randomly selected genes in (N) normal and 
(T) tumor groups. (A: data set A; B: data set B; AB: combined 
data sets)
Comparison of within-group correlations (AN, BN, AT, BT:  normal and tumor groups in data set A and data set B,  respectively) Figure 4
Comparison of within-group correlations (AN, BN, AT, BT: 
normal and tumor groups in data set A and data set B, 
respectively). ** P-value < 0.01.BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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top 500 genes of AB, indicating that our transformation
methods preserved the original biology of the data sets.
Eight genes were detected which belonged to AB' but A or
B. We investigated the relationship of these genes with
colorectal cancer and summarized the annotations of
these genes in Table 2. Chromosomal location 3q21-q24
was known as colorectal cancer (CRC) susceptible area
[16] and 4q33-q34 was identified as common genomic
alteration in CRC and genomic regions with altered DNA
copy numbers [17]. It is reported that biallelic germline
mutations in MYH are associated with colorectal neo-
plasm [18], MYH111, an isoform of MYH, could be sug-
gested as also related with colorectal cancer. Some genes
among 8 genes were colon cancer related genes or located
on close to a gene which is a colon cancer susceptible
gene. Therefore, we confirmed that the proposed method
could detect informative genes which might be lost by
using separated data sets.
We performed the simulation study using the arbitrary
data sets with various sample size, from 5 to 30, were sam-
pled from original data set. It was processed as following.
(1) Take random subsamples from data set A and data set
B (such as 5 tumor and 5 normal tissues from each set)
without replacement. This process was repeated 10 times
with same sample size for reducing sampling bias.
(2) Find the 500 significant genes list from the subsample
of A.
(3) Find the 500 significant genes list from (subsample
A)(subsample B) ', which is a combined data set with sub-
sample of A and transformed data set of subsample of B.
(4) Compare (2) and (3) with 500 significant genes list
selected from data set A.
Figure 10 showed that the usage of a combined data set is
more effective than separated data set and the proposed
method was seen more useful in a small data set. For
example, when the sample size is 5, the concurrency of
significant genes with those of data set A was increased
rapidly by using a combined data. The concurrency was
increased as the number of samples was increased.
The gene sets with a similar OOB (out-of-bag) error rate
were compared (information of each gene set not shown),
and none of the gene sets had 0% OOB error regardless of
the transformation methods. Only two significant genes
of data set AB' had 0.65% OOB error. Even if the number
of significant genes was increased to 500, the OOB error
Comparison of integration methods which are A'B, AB' and A'B', using density plots of five randomly selected genes from the  normal group (black: data set A, green: data set B, blue: transformed data set A in A'B and A'B', red: transformed data set B in  AB' and A'B') Figure 6
Comparison of integration methods which are A'B, AB' and A'B', using density plots of five randomly selected genes from the 
normal group (black: data set A, green: data set B, blue: transformed data set A in A'B and A'B', red: transformed data set B in 
AB' and A'B'). Horizontal and vertical axes represent gene expression values and relative frequency, respectively.BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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rate did not decrease. The prediction accuracies of top 500
significant genes were compared, and the prediction accu-
racies were 100% for all of transformation methods (data
not shown). In this case, integrated data sets by each trans-
formation method were used as training data sets to create
classifiers, and separated data sets were used for testing
these classifiers.
Discussion
An inescapable problem with combining several microar-
ray data sets is the variation of expressions between data
sets. In cases where the microarray analyses are from dif-
ferent experimental conditions, integration without trans-
formation may skew the expression ratios of the same
genes from different data sets. When the experimental
bias exceeds biological variation, the use of microarray
data sets without adjustments for this bias may make bio-
logical variation unidentifiable, meaning that reliable
results cannot be obtained. In addition, due to the limited
numbers of available microarray experiments, the motiva-
tion to use the whole data set, regardless of platforms or
experimental procedure, is increasing.
We attempted to minimize experimental bias by trans-
forming the expression ratios of the data sets such that
they have similar expression patterns in the correspond-
ing experimental groups of different data sets. Compared
with previous studies, the proposed transformation
method is a relatively simple algorithm [11-13], further-
more that showed good performance in various evalua-
tion methods. While a previous study used a reference
sample with average expression of whole experiments
including normal and tumor groups [14], the proposed
method considers biological differences that can be
existed between different experimental groups by trans-
forming expression ratios for each experimental group
separately.
Our method transforms expression ratios by three
approaches. In A'B, data set B was used as a reference data
set, data set A in AB'. A'B' is a combined data set after
transforming both of two data sets using pooled standard
deviation. In selecting the reference data set, we did not
consider biological meaning and we rather compared the
effects of transformation with diverse references. When a
method used a data set with strong homogeneity as a ref-
erence data set, its performance was slightly better than
other transformation methods as shown in Figure 9, but
there were no significant differences in efficiencies among
them, thus allowing a biological evaluation of the signifi-
cant genes of data sets integrated by each transformation
method.
Using a data set with homogeneity as a reference data set,
we observed that such characteristics are preserved in the
combined data set more strongly. Further, two separated
data sets can be well intermixed in a combined data set
because there are more chances that k NNs of a experi-
ment in one data set includes experiments of the other
data set (AB' in Figure 9). Also, the mean difference of
expressions between two experimental groups can be
larger as the homogeneity increases within the group.
Therefore, larger number of significant genes can be
selected from AB' as shown in Table 1.
RNA source effect in gene expression ratios was detected
in more than 5000 genes before transformation and such
effect was adjusted by the proposed methods.
Integration of datasets increases the sample size and
improves the analytical accuracy and statistical power of
the test. When focusing on significant gene selection,
ANOVA can be a flexible model to consider any clinical
information as well as genetic information with several
effect factors representing experimental conditions [15].
However, this method is applied to each gene and does
not create a combined data set for applying various statis-
tical methods to be able to identify additionally useful
biological information, such as gene expression patterns
through whole gene set. Therefore, for a given experimen-
tal question, i.e. complex genetic information including
expression patterns, it is useful to integrate data sets by
transformation prior to specific analysis.
The proposed integration method preserves the expres-
sion patterns of two data sets similar in corresponding
experimental groups, transforming the location and the
Comparison of within-group correlations Figure 7
Comparison of within-group correlations. (AB: combined 
data set before transformation; A'B, AB', A'B': combined data 
sets after transformation)BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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scale of the expression ratios and this method is available
to any data set with more than two groups. We confirmed
that the transformed data sets obtained from different
experimental environments were well intermixed, mean-
ing that the experimental bias was reduced. And most
genes among top 500 genes, which were selected from
combined data sets after transformation, were consistent
with top 500 genes selected from two original data sets.
This means that our method preserves original biology of
two data sets. In addition, we detected colorectal cancer
related genes which might be dropped in separated data
sets by using a combined data set. By simulation study, we
confirmed that the proposed method can detect more reli-
able information from a combined data and it is more
effective in small data sets derived from different experi-
mental conditions.
Conclusion
This method may not be appropriate when the different
experimental features in data sets include biological vari-
ations (for example, early disease stages of I and II in data
set A and advanced disease stages of III and IV in data set
B) because the expression values of a specific experimental
group are transformed into the form of the corresponding
experimental group of a reference data set. Thus, we sug-
gest that the proposed integration method is useful when
each data set includes phenotypically or biologically
homogenous experimental groups.
In conclusion, our method is simple and useful to com-
bine several datasets experimented under different experi-
mental conditions and available to any data set including
more than two groups. With this method, biologically
useful information can be detectable by applying various
analytic methods to combined data set with increased
sample size.
Comparison of integration methods which are AB, A'B, AB' and A'B', using unsupervised hierarchical cluster analysis Figure 8
Comparison of integration methods which are AB, A'B, AB' and A'B', using unsupervised hierarchical cluster analysis. All of data 
sets include two experimental groups, normal and tumor. Euclidean distance and average linkage method were used as similar-
ity measure and linkage method for hierarchical cluster analysis (pink: data set A; blue: data set B).BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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Methods
Tissue sample preparation
A total of 154 colorectal tissue samples (82 tumor and 72
normal) were obtained from colorectal cancer patients
who had undergone surgery at the Severance Hospital,
Yonsei University College of Medicine, Seoul, Korea.
Informed consent was obtained from patients prior to
using their surgical specimens and clinicopathologic data
for research purposes. Fresh tissues obtained from
patients were snap-frozen and stored at -80°C.
Microarrays
Total RNA was extracted from the tissues using Trizol (Inv-
itrogen, USA) and then purified using an RNeasy kit (Qia-
gen, Germany). The purified RNA samples were divided
into two groups for gene expression profiling using total
RNA and amplified mRNA. Gene expression profiling
using total RNA samples consisted of 20 paired normal
and tumor colon tissue samples, 23 tumor samples, and
15 normal colon tissues. This data set is used by data set A
in this study. Of the remaining 34 paired samples, 5
tumor and 3 normal colon tissues were used for gene
expression profiling with amplified mRNA, which was
obtained using the linear T7 mRNA amplification method
with the Megascript T7 kit (Ambion, USA). This data set is
used by data set B in this study. Each sample of total RNA
(50 ug) and amplified mRNA (2 ug) was directly labeled
with Cy5-dUTP and transcribed to cDNA. The microarray
experiment was performed using a reference design with
the Cy-3 dUTP labeled Yonsei reference RNA [19]. We
used the 17K human cDNA microarray (GenomicTree
Co., Daejon, Korea) for probe hybridization based on the
Yonsei Cancer Metastasis Research Center (CMRC, Yonsei
University, Korea) protocol [19]. Following hybridiza-
tion, microarrays were scanned using a GenePix 4000B
(Axon Ins., USA) and images were analyzed using Gene-
Pix Pro 4.0 (Axon Ins., USA).
These two microarray data sets have only difference on
RNA source. Previous studies have concluded that it is
vital to use equally treated samples for any particular
study, and all other samples should be amplified when
one sample requires amplification. In addition, the sensi-
tivity to detect differential gene expression from microar-
ray data set using amplified RNA was also different
compared to using total RNA [20,21]. Therefore, we used
these two data sets for evaluating our method.
Data normalization
Expression intensities were normalized such that they
would have similar distributions across a series of arrays.
In this study, the MAD (median-absolute-deviation) scale
estimator was used as a robust estimate of scale, and both
A-values, as well as the M-values, were normalized.
Within-slide and between slide normalization were used
to transform expression values to make intensities consist-
ent within each array and transform expression values to
achieve consistency between arrays, respectively. It was
necessary to apply between-slide normalization to the
expression data because there were different dispersions
between arrays after within-slide normalization. The nor-
malization process was executed using the 'limma' library
of the R package [22].
Table 1: Comparison of the numbers of significant genes.
Data set (method)/α 0.05 0.01
A 2325 2005
B 1654 1367
AB 2848 2488
A'B 3429 3088
AB' 4257 3868
A'B' 3453 3102
ANOVA 3337 (3302) 3004 (2961)
α: significant level by Bonferroni correction
The number in the parenthesis is the number of significant genes when ANOVA model included the interaction term.
Comparison of mixture score Figure 9
Comparison of mixture score. Pearson correlation coefficient 
was used as a similarity measure and k = 35.BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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Data transformation for combining data sets
The gene expression intensities of each data set were trans-
formed based on the reference data set by the following
three different methods to have similar expression pat-
terns in corresponding experimental group.
1) A'B: The gene expression ratios of data set A were trans-
formed into the form of data set B which is considered as
a reference data set. The transformed expression ratios of
normal and tumor groups in data set A were calculated for
each gene as follows:
where AN', AT': transformed expression ratios of normal
and tumor groups in data set A.
AN, AT: normal and tumor groups in data set A.
,  : mean expression ratios of tumor and normal
groups in data set B.
sd(AN),  sd(AT),  sd(BN),  sd(BT): standard deviation of
expression ratios of tumor and normal groups in data set
A and B.
2) AB': The gene expression ratios of data set B were trans-
formed into the form of data set A which is considered as
a reference data set. The transformed expression ratios of
normal and tumor groups in data set B were calculated for
each gene as follows:
where BN', BT': transformed expression ratios of normal
and tumor groups in data set B.
BN, BT: normal and tumor groups in data set B.
,  : mean expression ratios of tumor and normal
groups in data set A.
3) A'B': The gene expression ratios of data set A and data
set B were transformed using the pooled standard devia-
tion and mean expression values of the two data sets. The
transformed expression ratios of the normal and tumor
groups in data set A and data set B were calculated for each
gene as follows:
AN AN sd BN sd AN AN sd BN sd AN BN
AT AT sd BT
/
/
(( ) /( ) ) - [ (( ) /( ) ) - ) ]
(( )
=
= / / ( ))-[ ( ( )/ ( ))- )] sd AT AT sd BT sd AT BT
BN BT
BN BN sd AN sd BN BN sd AN sd BN AN
BT BT sd AT
/
/
(( ) /( ) ) - [ (( ) /( ) ) - ) ]
(( )
=
= / / ( ))-[ ( ( )/ ( ))- )] sd BT BT sd AT sd BT AT
AN AT
Table 2: Descriptions of 8 genes which were selected from AB' but A or B.
Gene ID UniGene ID Symbol Gene name Chromosomal Location
AI972269 Hs.556600 MYLK Myosin, light chain kinase 3q21
AA447632 Hs.75819 GPM6A Glycoprotein M6A 4q34
AA485871 Hs.286226 MYO1C Myosin IC 17p13
AI266457 Hs.527860 Transcribed locus 12
AI383497 Hs.189409 FNBP1 Formin binding protein 1 9q34
AA463926 Hs.444403 PPP1R12B Protein phosphatase 1, regulatory (inhibitor) subunit 12B 1q32.1 1q32.1
AI524093 Hs.460109 MYH11 Myosin, heavy chain 11, smooth muscle 16p13.11
AA213816 Hs.369574 CDC42EP3 CDC42 effector protein (Rho GTPase binding) 3 2p21
Comparison of the concurrency of significant gene sets Figure 10
Comparison of the concurrency of significant gene sets. The 
vertical and horizontal axes represent the number of sam-
pled experiments and the number of common significant 
genes, respectively. In legend, A and AB' represent subsample 
of A and a combined data set of subsample A and trans-
formed subsample B, respectively.BMC Bioinformatics 2007, 8:218 http://www.biomedcentral.com/1471-2105/8/218
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where  ,  : mean expression ratios of normal and
tumor groups in data set A and data set B.
: pooled
standard deviation of the normal group
: pooled
standard deviation of the tumor group
nAN, nBN, nAT, nBT: number of experiments of AN, BN, AT
and BT.
Evaluation of transformation method
We evaluated our proposed integration method by several
plots and mixture score, defined to evaluate the efficiency
of the integration method proposed in this study. The
principle of this metric is to measure how many k-nearest
neighbors (kNNs) of data set B in combined data set
belong to data set A. The metric was calculated as follows,
where k is the number of nearest neighbors (NNs).
Mixture score = #{x/x ∈ kNNs(data set B) n (data set A)}/k
where x is any experiment belonging to kNNs(data set B)
and data set A.
The mixture score ranges from 0 to 1. A value close to 0.5
is indicative of two different data sets that are perfectly
intermixed. Conversely, values close to either 0 or 1 indi-
cate a poor level of intermixing between the two different
data sets.
We evaluated the classification accuracies of selected gene
sets from integrated data sets by different transformation
methods and used Random Forest algorithm (RF) [23] for
this. We used RF program in R package [22] with the fol-
lowing steps.
(1) Generate n datasets of bootstrap samples {B1, B2,...,
Bn} by allowing repetition of the same sample.
(2) Use each sample Bk to construct a Tree classifier Tk to
predict those samples that are not in Bk, called out-of-bag
(OOB) samples. These predictions are called out-of-bag
estimators.
(3) Final prediction is the average of out-of-bag estimators
over all bootstrap samples and we get average of them
which is overall classification error (OOB error).
ANOVA (Analysis of Variance) model was used to evalu-
ate the RNA source effect of data sets derived from differ-
ent experimental conditions. ANOVA model used in this
work is as following.
gijk = μ + Ti + Rj + (TR)ij + εijk, εijk ~ N(0, σ2), i = 1, 2. j = 1, 
2. k = 1, 2,...,154.
where gijk is kth expression ratio of a gene in ith treatment
and jth RNA source. Ti, Rj and (TR)ij represent treatment
effect, RNA source effect and interaction effect, respec-
tively.
Abbreviations
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